(2017). Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients.
Chicago Style (17th ed.) CitationMolecular Resistance Mechanisms of ALK Inhibitors and Implications for Therapeutic Management of ALK-rearranged Lung Cancer Patients. 2017.
MLA (8th ed.) CitationMolecular Resistance Mechanisms of ALK Inhibitors and Implications for Therapeutic Management of ALK-rearranged Lung Cancer Patients. 2017.
Warning: These citations may not always be 100% accurate.